(Reuters) -Roche Group said on Monday that it plans to invest more than $700 million in a new drug manufacturing facility in ...

HOLLY SPRINGS, N.C. -- Genentech, a leading biotechnology company based in San Francisco, is set to build a $700 million ...

Genentech has announced plans to invest more than $700 million in a new 700,000 square foot drug manufacturing facility.

The committee awarded a grant to Genentech, a Roche subsidiary, to open a 420-worker, drug-manufacturing plant in the fast-growing part of southwestern Wake County. Roche pledged ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today plans to invest more than $700 million ...

A Wake County town is in line for another major investment from a large pharma company. © 2025 American City Business ...